Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

SELL
$4.86 - $8.19 $7,620 - $12,841
-1,568 Reduced 16.77%
7,782 $51,000
Q4 2023

Jan 30, 2024

SELL
$3.37 - $6.86 $6,163 - $12,546
-1,829 Reduced 16.36%
9,350 $60,000
Q3 2023

Oct 25, 2023

SELL
$4.7 - $8.55 $1,297 - $2,359
-276 Reduced 2.41%
11,179 $56,000
Q2 2023

Aug 07, 2023

BUY
$7.35 - $13.29 $65,951 - $119,251
8,973 Added 361.52%
11,455 $100,000
Q1 2023

May 08, 2023

SELL
$7.91 - $12.0 $20,312 - $30,816
-2,568 Reduced 50.85%
2,482 $29,000
Q4 2022

Feb 01, 2023

BUY
$4.62 - $10.18 $23,331 - $51,409
5,050 New
5,050 $51,000

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $220M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.